Google
Trusted Resources: News & Events
Latest announcements and gatherings
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (HR 2410, 115th Congress)
The Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (HR 2410) is designed to reauthorize expired federal sickle cell disease programs and establish new federal sickle cell disease research, surveillance, prevention, and treatment programs.
HR 2410 amends section 399V of title III of the Public Health Service Act (42 U.S.C. 280g-11 et seq.) to authorize the Department of Health and Human Services to undertake the following research and surveillance efforts:
- Establish research efforts to explore causes and cures for the disease.
- Award grants to entities in up to 20 states that demonstrate collaboration with other communal organizations and healthcare providers to:
-Collect data on the prevalence and demographics of sickle cell disease
-Organize public health initiatives
-Research potential prevention and treatment strategies
+myBinderRelated Content
-
Queens’s boy, 13, among advocates, doctors in Albany to champion new sickle cell billParker Todd, 13, of Queens, was joined...
-
2022 Annual Advocacy Day Event – SCDAASickle Cell Disease Association of Ameri...
-
Sickle cell advocate wins fight for high-dose opioidsGeorge H. Carter appears to have won h...
-
Rare Disease Week on Capitol HillNow in its 12th year, Rare Disease Week ...
-
Improving Vaso-Occlusive Crisis ManagementMany have spoken out about the need for ...
-
Annual Sickle Cell Day Event by Sickle Cell Foundation of Georgia (SCFG)Join us for Sickle Cell Day at the Georg...
-
Improving vaso-occlusive crisis (VOC) management for those living with sickle cell diseaseThe Sickle Cell Disease Council For CHAN...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.